Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This is a phase 2, multi-country, randomized, double-blind, placebo-controlled trial to evaluate the immune response to routine pediatric vaccinations when co-administered with HIL-214 or placebo in healthy infants. This trial will also evaluate the safety profile of a 2-dose regimen of HIL-214 co-administered with routine pediatric vaccines.
Epistemonikos ID: c98b9dc4c4dc115ac8abf8c7ee069fcd139d42a0
First added on: Oct 02, 2023